Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

sofosbuvir-velpatasvir drug combination 1saxagliptin 1dapagliflozin 1amlodipine, atorvastatin drug combination 1Urine Specimen Collection 1Methods 1Metformin 1Interviews as Topic 1Exercise 1Educational Status 1Early Intervention, Educational 1Blood Specimen Collection 1Biopsy 1Behavior Therapy 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Diabetes Mellitus × saxagliptin × Clear all
NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting
600 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡